Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Their goal is to provide money and mentoring to the life science community to achieve superior returns for their group, and more clinical innovation for the community.
|Avaxia Biologics||6/2013||Series B||$11.5M||10|
|Avaxia Biologics||2/2012||Series A||$4.1M||6|
|Bliss Healthcare||2/2011||Series A||$500k||3|
|Polytouch Medical||9/2010||Venture Round||$830k||1|
|Lantos Technologies||9/2010||Series A||$1.6M||3|
|Daktari Diagnostics||10/2009||Series A||$2.8M||6|